Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease

被引:37
|
作者
Ayoub, Mohammed Akli [1 ,2 ]
Zhang, Yuan [3 ]
Kelly, Robyn S. [3 ]
See, Heng B. [1 ,2 ]
Johnstone, Elizabeth K. M. [1 ,2 ]
McCall, Elizabeth A. [4 ]
Williams, James H. [4 ]
Kelly, Darren J. [3 ]
Pfleger, Kevin D. G. [1 ,2 ,4 ]
机构
[1] QEII Med Ctr, Harry Perkins Inst Med Res, Mol Endocrinol & Pharmacol, Nedlands, WA, Australia
[2] Univ Western Australia, Med Res Ctr, Crawley, WA, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
[4] Dimerix Biosci Ltd, Nedlands, WA, Australia
来源
PLOS ONE | 2015年 / 10卷 / 03期
基金
澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
RESONANCE ENERGY-TRANSFER; KAPPA-B ACTIVATION; MACROPHAGE INFILTRATION; RENAL INJURY; EXPRESSION; RAT; HETEROMERIZATION; RECRUITMENT; INHIBITION; APOPTOSIS;
D O I
10.1371/journal.pone.0119803
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Understanding functional interactions between G protein-coupled receptors is of great physiological and pathophysiological importance. Heteromerization provides one important potential mechanism for such interaction between different signalling pathways via macromolecular complex formation. Previous studies suggested a functional interplay between angiotensin II receptor type 1 (AT(1)) and Chemokine (C-C motif) Receptor 2 (CCR2). However the molecular mechanisms are not understood. We investigated AT(1)-CCR2 functional interaction in vitro using bioluminescence resonance energy transfer in HEK293 cells and in vivo using subtotal-nephrectomized rats as a well-established model for chronic kidney disease. Our data revealed functional heteromers of these receptors resulting in CCR2-G alpha i1 coupling being sensitive to AT(1) activation, as well as apparent enhanced beta-arrestin2 recruitment with agonist co-stimulation that is synergistically reversed by combined antagonist treatment. Moreover, we present in vivo findings where combined treatment with AT(1)- and CCR2-selective inhibitors was synergistically beneficial in terms of decreasing proteinuria, reducing podocyte loss and preventing renal injury independent of blood pressure in the subtotal-nephrectomized rat model. Our findings further support a role for G protein-coupled receptor functional heteromerization in pathophysiology and provide insights into previous observations indicating the importance of AT(1)-CCR2 functional interaction in inflammation, renal and hypertensive disorders.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] A Chemokine C-C motif receptor 2 Antagonist, INCB3344, Reverses Hypertension and Macrophage Accumulation in the Artery Wall in Angiotensin II-Treated Mice
    Moore, Jeffrey P.
    Chan, Christopher
    Sakkal, Samy
    Ricardo, Sharon L.
    Sobey, Christopher G.
    Drummond, Grant R.
    CIRCULATION, 2012, 126 (21)
  • [42] Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice
    Heymann, Felix
    Hammerich, Linda
    Storch, Dunja
    Bartneck, Matthias
    Huss, Sebastian
    Ruesseler, Vanessa
    Gassler, Nikolaus
    Lira, Sergio A.
    Luedde, Tom
    Trautwein, Christian
    Tacke, Frank
    HEPATOLOGY, 2012, 55 (03) : 898 - 909
  • [43] Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
    Iwamoto, Hiroaki
    Izumi, Kouji
    Mizokami, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 16
  • [44] Relationships Between Metformin, Paraoxonase-1 and the Chemokine (C-C Motif) Ligand 2
    Camps, Jordi
    Hernandez-Aguilera, Anna
    Garcia-Heredia, Anabel
    Cabre, Noemi
    Luciano-Mateo, Fedra
    Arenas, Meritxell
    Joven, Jorge
    CURRENT CLINICAL PHARMACOLOGY, 2016, 11 (04): : 250 - 258
  • [45] Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease
    Su, Sui-Lung
    Chen, Wei-Teing
    Hsiao, Po-Jen
    Lu, Kuo-Cheng
    Lin, Yuh-Feng
    Lin, Chin
    Su, Wen
    Yeh, Shih-Jen
    Chang, Hung
    Lin, Fu-Huang
    ONCOTARGET, 2017, 8 (64) : 107833 - 107843
  • [46] Chemerin attracts neutrophil reverse migration by interacting with C-C motif chemokine receptor-like 2
    Ji, Jingjing
    Zhong, Hanhui
    Wang, Yawen
    Liu, Jinghua
    Tang, Jing
    Liu, Zhifeng
    CELL DEATH & DISEASE, 2024, 15 (06):
  • [47] Activation of C-C motif chemokine receptor 2 modulates testicular macrophages number, steroidogenesis, and spermatogenesis progression
    Figueiredo, A. F. A.
    Wnuk, N. T.
    Vieira, C. P.
    Goncalves, M. F. F.
    Brener, M. R. G.
    Diniz, A. B.
    Antunes, M. M.
    Castro-Oliveira, H. M.
    Menezes, G. B.
    Costa, G. M. J.
    CELL AND TISSUE RESEARCH, 2021, 386 (01) : 173 - 190
  • [48] C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape
    Guo, Yangkun
    Zhao, Chong
    Dai, Wenting
    Wang, Bowen
    Lai, Enjiang
    Xiao, Yang
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (08): : 2572 - 2587
  • [49] C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
    Anderson, Matthew W.
    Zhao, Shuchun
    Ai, Weiyun Z.
    Tibshirani, Robert
    Levy, Ronald
    Lossos, Izidore S.
    Natkunam, Yasodha
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (03) : 473 - 483
  • [50] INHIBITION C-C CHEMOKINE RECEPTOR TYPE 2 (CCR2) ON ACTIVATED KIDNEY PARIETAL EPITHELIAL CELLS REVEALS A NEW THERAPEUTIC APPROACH FOR CHRONIC KIDNEY DISEASES
    Zhao, Bin
    Miao, Zhenhua
    Campbell, James
    Ertl, Linda S.
    Wang, Yu
    Li, Chris
    Singh, Rajinder
    Charo, Israel F.
    Schall, Thomas J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 274 - 274